ATP6AP2 and Parkinson disease: On the other hand, it was demonstrated that administration of PRR blocker significantly decreased 6-hydroxydopamine-induced dopamine cell death in the cultures, suggesting that the potential neuroprotective strategies for dopamine neurons in Parkinson's disease should address not only Ang II but also PRR signaling [113].